What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options

Breast-cancer-related lymphedema (BCRL) is a common consequence of oncological treatment. Its management is a complicated, chronic, and arduous process. Therapeutic options can be divided on non-surgical and surgical methods, although there is still no clear consensus about their effectiveness in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Anuszkiewicz, Karolina, Jankau, Jerzy, Kur, Martyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950281/
https://www.ncbi.nlm.nih.gov/pubmed/36571707
http://dx.doi.org/10.1007/s12282-022-01428-z
_version_ 1784893132231409664
author Anuszkiewicz, Karolina
Jankau, Jerzy
Kur, Martyna
author_facet Anuszkiewicz, Karolina
Jankau, Jerzy
Kur, Martyna
author_sort Anuszkiewicz, Karolina
collection PubMed
description Breast-cancer-related lymphedema (BCRL) is a common consequence of oncological treatment. Its management is a complicated, chronic, and arduous process. Therapeutic options can be divided on non-surgical and surgical methods, although there is still no clear consensus about their effectiveness in preventing or stopping the disease. That brings problems in everyday practice, as there are no guidelines about proper time for starting therapy and no agreement about which management will be beneficial for each patient. The aim of this review is to summarize current knowledge about possible treatment choices, non-surgical so as surgical, indicate knowledge gaps, and try to direct pathways for future studies.
format Online
Article
Text
id pubmed-9950281
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-99502812023-02-25 What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options Anuszkiewicz, Karolina Jankau, Jerzy Kur, Martyna Breast Cancer Review Article Breast-cancer-related lymphedema (BCRL) is a common consequence of oncological treatment. Its management is a complicated, chronic, and arduous process. Therapeutic options can be divided on non-surgical and surgical methods, although there is still no clear consensus about their effectiveness in preventing or stopping the disease. That brings problems in everyday practice, as there are no guidelines about proper time for starting therapy and no agreement about which management will be beneficial for each patient. The aim of this review is to summarize current knowledge about possible treatment choices, non-surgical so as surgical, indicate knowledge gaps, and try to direct pathways for future studies. Springer Nature Singapore 2022-12-26 2023 /pmc/articles/PMC9950281/ /pubmed/36571707 http://dx.doi.org/10.1007/s12282-022-01428-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Anuszkiewicz, Karolina
Jankau, Jerzy
Kur, Martyna
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
title What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
title_full What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
title_fullStr What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
title_full_unstemmed What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
title_short What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
title_sort what do we know about treating breast-cancer-related lymphedema? review of the current knowledge about therapeutic options
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950281/
https://www.ncbi.nlm.nih.gov/pubmed/36571707
http://dx.doi.org/10.1007/s12282-022-01428-z
work_keys_str_mv AT anuszkiewiczkarolina whatdoweknowabouttreatingbreastcancerrelatedlymphedemareviewofthecurrentknowledgeabouttherapeuticoptions
AT jankaujerzy whatdoweknowabouttreatingbreastcancerrelatedlymphedemareviewofthecurrentknowledgeabouttherapeuticoptions
AT kurmartyna whatdoweknowabouttreatingbreastcancerrelatedlymphedemareviewofthecurrentknowledgeabouttherapeuticoptions

Ejemplares similares